Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1872)
All Articles published online
|
Jul 14, 2005 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen GY, He JQ, Lu GC, Li MW, Xu CH, Fan WW, Zhou C, Chen Z. Association between TRAIL expression on peripheral blood lymphocytes and liver damage in chronic hepatitis B. World J Gastroenterol 2005; 11(26): 4090-4093 [PMID: 15996036 DOI: 10.3748/wjg.v11.i26.4090] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i26/4090.htm |
| Number | Citing Articles |
| 1 |
Nadia Corazza, Anastasia Badmann, Christoph Lauer. Immune cell-mediated liver injury. Seminars in Immunopathology 2009; 31(2): 267 doi: 10.1007/s00281-009-0168-1
|
| 2 |
Hang Zhang, Changxin Huang, Yan Wang, Zhe Lu, Ningtong Zhuang, Dongjiu Zhao, Jianqin He, Liyun Shi, Dominique Delmas. Hepatitis B Virus X Protein Sensitizes TRAIL-Induced Hepatocyte Apoptosis by Inhibiting the E3 Ubiquitin Ligase A20. PLOS ONE 2015; 10(5): e0127329 doi: 10.1371/journal.pone.0127329
|
| 3 |
Lu Ning, Xuan Huang, Ying Xu, Guifeng Yang, Juncheng Yang, Qunfang Fu, Qi Zhang, Hai Liu, Xiaoting Wu, Zhanhui Wang, Kangxian Luo. Boosting of Hepatitis B Virus-Specific T Cell Responses After Pegylated-Interferon-α-2a Therapy for Hepatitis B e Antigen-Positive Pediatric Patients. Journal of Interferon & Cytokine Research 2019; 39(12): 740 doi: 10.1089/jir.2019.0042
|
| 4 |
Yujie Jiang, Shuang Qin, Xin Wei, Xiaoyuan Liu, Jingjing Guan, Hengyue Zhu, Guolin Chang, Yingxiao Chen, Hong Lu, Jingjing Qian, Zhongyong Wang, Mo Shen, Xiangyang Lin. Highly activated TRAIL+ CD56bright NK cells are associated with the liver damage in HBV-LC patients. Immunology Letters 2021; 232: 9 doi: 10.1016/j.imlet.2020.12.008
|
| 5 |
Wei Jiang, Dong-Bo Wu, Si-Yu Fu, En-Qiang Chen, Hong Tang, Tao-You Zhou. Insight into the role of TRAIL in liver diseases. Biomedicine & Pharmacotherapy 2019; 110: 641 doi: 10.1016/j.biopha.2018.12.004
|
| 6 |
A Piekarska, R Kubiak, A Omulecka, W Szymczak, J Piekarski. Expression of tumour necrosis factor‐related apoptosis‐inducing ligand and caspase‐3 in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C. Histopathology 2007; 51(5): 597 doi: 10.1111/j.1365-2559.2007.02863.x
|
| 7 |
Jason L. Girkin, Luke M. Hatchwell, Adam M. Collison, Malcolm R. Starkey, Philip M. Hansbro, Hideo Yagita, Paul S. Foster, Joerg Mattes. TRAIL signaling is proinflammatory and proviral in a murine model of rhinovirus 1B infection. American Journal of Physiology-Lung Cellular and Molecular Physiology 2017; 312(1): L89 doi: 10.1152/ajplung.00200.2016
|
| 8 |
Fan-wei Liu, Dong-bo Wu, En-qiang Chen, Cong Liu, Li Liu, Shou-chun Chen, Dao-yin Gong, Lian-san Zhao, Hong Tang, Tao-you Zhou. Expression of TRAIL in liver tissue from patients with different outcomes of HBV infection. Clinics and Research in Hepatology and Gastroenterology 2013; 37(3): 269 doi: 10.1016/j.clinre.2012.09.009
|
| 9 |
David M Iser, Sharon R Lewin. The pathogenesis of liver disease in the setting of HIV–hepatitis B virus coinfection. Antiviral Therapy 2009; 14(2): 155 doi: 10.1177/135965350901400207
|